Immunotherapy in GU Cancers

Publication
Article
Special ReportsImmunotherapy (Issue 5)
Volume 5
Issue 1

Mark A. Rubin, MD, director, Institute for Precision Medicine, Weill Cornell Medical College, discusses immunotherapy in the field of genitourinary cancers.

Mark A. Rubin, MD, director, Institute for Precision Medicine, Weill Cornell Medical College, discusses immunotherapy in the field of genitourinary cancers.

<<<

View the entire Special Report on Immunotherapy

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
1 expert in this video
1 expert in this video
Related Content